Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of Dec 28, 2024, Hologic, Inc.'s fair value using the Ben Graham formula is $171.0 per share. This is calculated using Ben Graham formula, where EPS is $3.2 and BVPS (Book Value Per Share) is $20.4. The current price of $63.3 suggests Hologic, Inc. may be overvalued by this conservative metric.
Hologic, Inc. earnings per share (EPS) for the twelve months ending Dec 28, 2024, was $3.2, a 27.1% growth year-over-year.
Hologic, Inc.'s margin of safety is positive 170.3%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.